Healthcare -
Biotechnology - NASDAQ - BM
$ 21.98
8.38 %
$ 1.6 B
Market Cap
-36.63
P/E
KNSA - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss KNSA - Kiniksa Pharmaceuticals, Ltd.
6 K
LAST VALUE
44.60%
2 YEAR CAGR
28.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR